Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0001354488-14-000422
Filing Date
2014-01-31
Accepted
2014-02-03 07:38:16
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM S-4 sbfm_s4.htm S-4 2154262
2 OPINION OF ANDREW I. TELSEY, P.C. RE: LEGALITY sbfm_ex52.htm EX-5.2 8213
3 FORM OF LOCK- UP LETTER AGREEMENT sbfm_ex105.htm EX-10.5 5298
4 CONSENT OF BEN BORGERS CPA PC sbfm_ex232.htm EX-23.2 3323
5 CONSENT OF ANDREW I. TELSEY, P.C. sbfm_ex233.htm EX-23.3 4365
6 figure1.jpg GRAPHIC 15800
7 figure2.jpg GRAPHIC 20675
8 table1.jpg GRAPHIC 14507
9 table2.jpg GRAPHIC 12552
10 appendixcpage1.jpg GRAPHIC 54946
11 appendixcpage2.jpg GRAPHIC 92932
12 appendixcpage3.jpg GRAPHIC 90748
13 appendixcpage4.jpg GRAPHIC 91308
14 appendixcpage5.jpg GRAPHIC 37888
15 appendixcpage6.jpg GRAPHIC 48030
16 auditorimg.jpg GRAPHIC 1842
17 auditorimg2.jpg GRAPHIC 12833
  Complete submission text file 0001354488-14-000422.txt   2858891
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: S-4 | Act: 33 | File No.: 333-193719 | Film No.: 14566524
SIC: 8742 Services-Management Consulting Services